Release Date: November 2018
Available for CMLE Only
Nils B. Person, PhD, FACB
Senior Clinical Consultant, Siemens Healthineers, Tarrytown, NY
Description:
This course will assist laboratory staff deal with the challenges associated with starting a new reagent lot such as QC results shifting and verifying the performance of a new reagent lot. The EP26 CLSI published guidelines for User Evaluation of Between-Reagent Lot Variation provide a practical solution to this common issue. These protocols will be reviewed in an effort to provide guidance on best practices.
After attending this session, participants will be able to:
- Discuss the challenges of evaluating a new reagent lot.
- Describe the impact of QC sample matrix on evaluating new reagent lots.
- Highlight the guidelines provided in the CLSI EP26 document for evaluating a new reagent lot.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Laboratory Managers, Bench Supervisors, Bench Technologists & Technicians